December 21, 2025 a 01:00 pm
AFL: Analysts Ratings - Aflac Incorporated
Aflac Incorporated, a key player in supplemental health and life insurance, displays a mixed sentiment among analysts. While the company's diverse product offerings in both Japan and the U.S. provide a solid business foundation, recent analyst ratings suggest a cautious outlook. The predominance of Hold ratings indicates a wait-and-see attitude among analysts, possibly reflecting market uncertainties or sector-specific challenges.
Historical Stock Grades
| Category | Number | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 1 | |
| Hold | 8 | |
| Sell | 2 | |
| Strong Sell | 1 |
Sentiment Development
The analyst sentiment for Aflac Incorporated has shown stability with a consistent emphasis on Hold ratings. Over recent months, the total number of ratings has remained relatively stable, indicating a steady market perspective. Notably, there's a slight uptick in Sell ratings, suggesting some growing concerns. Simultaneously, the Strong Buy recommendations have held firm, reflecting a subset of analysts who see strong potential.
Percentage Trends
- The shift from Buy to Hold ratings suggests increasing caution or uncertainty regarding Aflac's market performance.
- Strong Buy ratings remain low, displaying a lack of aggressive bullish sentiment amongst analysts.
- A gradual increase in Hold ratings is potentially indicative of a conservative outlook or waiting for more positive market signals.
- Recent months show a minor increase in Sell recommendations, warranting attention to potential downside risks.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-17 | Equal Weight | Equal Weight | Morgan Stanley |
| 2025-11-07 | Underperform | Underperform | Evercore ISI Group |
| 2025-11-07 | Equal Weight | Equal Weight | Wells Fargo |
| 2025-11-05 | Underweight | Underweight | Barclays |
| 2025-11-05 | Neutral | Neutral | JP Morgan |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2024-01-04 | Underperform | In Line | Evercore ISI Group |
| 2023-08-18 | Equal Weight | Overweight | Morgan Stanley |
| 2023-08-17 | Equal Weight | Overweight | Morgan Stanley |
| 2021-01-12 | Overweight | Equal Weight | Morgan Stanley |
| 2021-01-11 | Overweight | Equal Weight | Morgan Stanley |
Interpretation
The predominance of Hold ratings for Aflac Incorporated points to a cautious market stance, with analysts displaying a tentative outlook amidst potential uncertainties in the insurance sector. An uptick in Sell and Strong Sell ratings could suggest emerging concerns over the company's performance in Japan and the U.S. However, the presence of Strong Buy ratings indicates optimism from a few analysts, highlighting a belief in Aflac's strategic initiatives or market resilience. The current sentiment points towards moderate stability, with opinions possibly flagging temporary caution.
Conclusion
Aflac's stock is navigating through a period of moderate stability with cautious analyst sentiment largely characterized by Hold ratings. The observed increase in Sell ratings raises a red flag for potential challenges, yet a stable number of Strong Buy recommendations reflects underlying confidence. The company's robust product portfolio across diverse insurance segments presents opportunities even amid cautious sentiment. Analysts may be awaiting more definitive metrics before adjusting ratings, reflecting a tendency towards prudence amidst market volatility.